Is there evidence to claim or deny association between variants of the multidrug resistance gene (MDR1 or ABCB1) and inflammatory bowel disease?

Inflammatory Bowel Diseases

Volumn 18, Issue 3, 2012, Pages 562-572

  Zintzaras, Elias ^a,b  

^a UNIVERSITY OF THESSALY   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Crohn's disease; inflammatory bowel disease; MDR1; ulcerative colitis

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1;

DNA POLYMORPHISM; ENTERITIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; META ANALYSIS (TOPIC); MUTATION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

ALLELES; COLITIS, ULCERATIVE; CROHN DISEASE; HUMANS; ODDS RATIO; P-GLYCOPROTEIN;

EID: 84857364174     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21728     Document Type: Review

References (68)

1. Baumgart DC, Carding SR,. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007; 369: 1627-1640. (Pubitemid 46722636)
2. Orholm M, Munkholm P, Langholz E, et al. Familial occurrence of inflammatory bowel disease. N Engl J Med. 1991; 324: 84-88.
3. Ho GT, Moodie FM, Satsangi J,. Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? Gut. 2003; 52: 759-766. (Pubitemid 36528884)
4. Lawrance IC, Fiocchi C, Chakravarti S,. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet. 2001; 10: 445-456. (Pubitemid 32181667)
5. Langmann T, Moehle C, Mauerer R, et al. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology. 2004; 127: 26-40. (Pubitemid 38962271)
6. Kimchi-Sarfaty C, Oh JM, Kim IW, et al. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science. 2007; 315: 525-528. (Pubitemid 46175758)
7. Tahara T, Shibata T, Nakamura M, Yamashita H, et al. Effect of MDR1 gene promoter methylation in patients with ulcerative colitis. Int J Mol Med. 2009; 23: 521-527.
8. Soranzo N, Cavalleri GL, Weale ME, et al. Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene. Genome Res. 2004; 14: 1333-1344. (Pubitemid 39029230)
9. Fung KL, Gottesman MM,. A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochim Biophys Acta. 2009; 1794: 860-871.
10. Onnie CM, Fisher SA, Pattni R, et al. Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis study. Inflamm Bowel Dis. 2006; 12: 263-271.
11. Annese V, Valvano MR, Palmieri O, et al. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. World J Gastroenterol. 2006; 12: 3636-3644. (Pubitemid 43950939)
12. Zintzaras E, Lau J,. Trends in meta-analysis of genetic association studies. J Hum Genet. 2008; 53: 1-9.
13. Lau J, Antman EM, Jimenez-Silva J, et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992; 327: 248-254.
14. Zintzaras E, Lau J,. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol. 2008; 61: 634-645. (Pubitemid 351766746)
15. Trikalinos TA, Salanti G, Zintzaras E, et al. Meta-analysis methods. Adv Genet. 2008; 60: 311-334.
16. Zintzaras E., The generalized odds ratio as a measure of genetic risk effect in the analysis and meta-analysis of association studies. Stat Appl Genet Mol Biol. 2010;9:Article21.
17. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7: 177-188. (Pubitemid 17189972)
18. Harbord RM, Egger M, Sterne JA,. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006; 25: 3443-3457. (Pubitemid 44575162)
19. Weir B,. Genetic Data Analysis II: Methods for Discrete Population Genetic Data. Sunderland, MA: Sinauer Associates; 1996.
20. Zintzaras E,. Variance estimation of allele-based odds ratio in the absence of Hardy-Weinberg equilibrium. Eur J Epidemiol. 2008; 23: 323-326.
21. Brant SR, Panhuysen CI, Nicolae D, et al. MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet. 2003; 73: 1282-1292. (Pubitemid 38037422)
22. Asano K, Matsushita T, Umeno J, et al. A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat Genet. 2009; 41: 1325-1329.
23. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008; 40: 955-962.
24. Chen X, Li X, Wang P, Liu Y, et al. Novel association strategy with copy number variation for identifying new risk Loci of human diseases. PLoS One. 2010; 5: e12185.
25. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006; 314: 1461-1463. (Pubitemid 44871953)
26. Feng T, Zhu X,. Genome-wide searching of rare genetic variants in WTCCC data. Hum Genet. 2010; 128: 269-280.
27. Festen EA, Stokkers PC, van Diemen CC, et al. Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk. Am J Gastroenterol. 2010; 105: 395-402.
28. Franke A, Balschun T, Karlsen TH, et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet. 2008; 40: 713-715. (Pubitemid 351748866)
29. Franke A, Balschun T, Karlsen TH, et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet. 2008; 40: 1319-1323.
30. Franke A, Balschun T, Sina C, et al. Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet. 2010; 42: 292-294.
31. Franke A, Fischer A, Nothnagel M, et al. Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2. Gastroenterology. 2008; 135: 1207-1215.
32. Franke A, Hampe J, Rosenstiel P, et al. Systematic association mapping identifies NELL1 as a novel IBD disease gene. PLoS ONE. 2007; 2: e691.
33. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010; 42: 1118-1125.
34. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007; 39: 207-211. (Pubitemid 46184351)
35. Haritunians T, Taylor KD, Targan SR, et al. Genetic predictors of medically refractory ulcerative colitis. Inflamm Bowel Dis. 2010; 16: 1830-1840.
36. Imielinski M, Baldassano RN, Griffiths A,. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet. 2009; 41: 1335-1340.
37. Kugathasan S, Baldassano RN, Bradfield JP, et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet. 2008; 40: 1211-1215.
38. Libioulle C, Louis E, Hansoul S, et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 2007; 3: e58.
39. McGovern DP, Gardet A, Törkvist L, et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet. 2010; 42: 332-337.
40. McGovern DP, Jones MR, Taylor KD, et al. Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Hum Mol Genet. 2010; 19: 3468-3476.
41. Raelson JV, Little RD, Ruether A, et al. Genome-wide association study for Crohn's disease in the Quebec founder population identifies multiple validated disease loci. Proc Natl Acad Sci U S A. 2007; 104: 14747-14752. (Pubitemid 350003214)
42. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007; 39: 596-604. (Pubitemid 46676115)
43. Silverberg MS, Cho JH, Rioux JD, et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet. 2009; 41: 216-220.
44. UK IBD Genetics Consortium. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet. 2009; 41: 1330-1334.
45. Wang K, Zhang H, Kugathasan S, et al. Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn disease. Am J Hum Genet. 2009; 84: 399-405.
46. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007; 447: 661-678.
47. Wellcome Trust Case Control Consortium. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature. 2010; 464: 713-720.
48. Yamazaki K, McGovern D, Ragoussis J, et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet. 2005; 14: 3499-3506. (Pubitemid 41672132)
49. Osuga T, Sakaeda T, Nakamura T, et al. MDR1 C3435T polymorphism is predictive of later onset of ulcerative colitis in Japanese. Biol Pharm Bull. 2006; 29: 324-329. (Pubitemid 43200905)
50. Farnood A, Naderi N, Moghaddam SJ, et al. The frequency of C3435T MDR1 gene polymorphism in Iranian patients with ulcerative colitis. Int J Colorectal Dis. 2007; 22: 999-1003. (Pubitemid 47500239)
51. Juyal G, Midha V, Amre D, et al. Associations between common variants in the MDR1 (ABCB1) gene and ulcerative colitis among North Indians. Pharmacogenet Genomics. 2009; 19: 77-85.
52. Krupoves A, Seidman EG, Mack D, et al. Associations between ABCB1/MDR1 gene polymorphisms and Crohn's disease: a gene-wide study in a pediatric population. Inflamm Bowel Dis. 2009; 15: 900-908.
53. Huebner C, Browning BL, Petermann I, et al. Genetic analysis of MDR1 and inflammatory bowel disease reveals protective effect of heterozygous variants for ulcerative colitis. Inflamm Bowel Dis. 2009; 15: 1784-1793.
54. Ho GT, Nimmo ER, Tenesa A, et al. Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology. 2005; 128: 288-296. (Pubitemid 40431082)
55. Oostenbrug LE, Dijkstra G, Nolte IM, et al. Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease. Scand J Gastroenterol. 2006; 41: 1174-1182. (Pubitemid 44451680)
56. Urcelay E, Mendoza JL, Martín MC, et al. MDR1 gene: susceptibility in Spanish Crohn's disease and ulcerative colitis patients. Inflamm Bowel Dis. 2006; 12: 33-37. (Pubitemid 43032449)
57. Palmieri O, Latiano A, Valvano R, et al. Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients. Aliment Pharmacol Ther. 2005; 22: 1129-1138. (Pubitemid 41779521)
58. Sapmaz A, Ozen Karatayli SC, Daǧli U, et al. Effects of polymorphism in G2677T/A triallelic region of MDR1 gene in Turkish patients with inflammatory bowel disease. Turk J Gastroenterol. 2008; 19: 168-173.
59. Schwab M, Schaeffeler E, Marx C, et al. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology. 2003; 124: 26-33. (Pubitemid 36055335)
60. Glas J, Török HP, Schiemann U, et al. MDR1 gene polymorphism in ulcerative colitis. Gastroenterology. 2004; 126: 367. (Pubitemid 38040750)
61. Fischer S, Lakatos PL,; Hungarian IBD Study Group, et al. ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases. Scand J Gastroenterol. 2007; 42: 726-733. (Pubitemid 46763580)
62. Goldstein DB,. Common genetic variation and human traits. N Engl J Med. 2009; 360: 1696-1698.
63. Lau J, Ioannidis JP, Terrin N, et al. The case of the misleading funnel plot. BMJ. 2006; 333: 597-600. (Pubitemid 44433638)
64. Zintzaras E,. Genetic variants of homocysteine/folate metabolism pathway and risk of inflammatory bowel disease: a synopsis and meta-analysis of genetic association studies. Biomarkers. 2010; 15: 69-79.
65. Cooper RS, Kaufman JS, Ward R,. Race and genomics. N Engl J Med. 2003; 348: 1166-1170. (Pubitemid 36337329)
66. Zintzaras E, Kitsios G, Stefanidis I,. Response to endothelial nitric oxide synthase polymorphisms and susceptibility to hypertension: genotype versus haplotype analysis. Hypertension. 2006;PMID:17088443.
67. Chapman J, Clayton D,. Detecting association using epistatic information. Genet Epidemiol. 2007; 31: 894-909.
68. Clayton D, McKeigue PM,. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet. 2001; 358: 1356-1360. (Pubitemid 33016504)